| ¿µ¹® | linear accelerator | ÇÑ±Û | ¼±»ó°¡¼Ó±â |
|---|---|---|---|
| ¼³¸í | Ä¡·á¹æ»ç¼±°ú¿¡¼ ÀÌ¿ëÇÏ´Â ±â°è·Î¼ ÀüÀÚ¸¦ »ý¼ºÇØ ³½´Ù. ÀüÀÚ´Â ´Ü¼øÈ÷ X-¼±°ú´Â ´Ù¸¥ °ÍÀ¸·Î ÀüÀÚ°¡ ±Ý¼Ó¿¡ ºÎµúÇô ³ª¿À´Â °ÍÀÌ X-¼±ÀÌ´Ù. ÀüÀÚ´Â Áø´Ü¸ñÀûº¸´Ù´Â Ä¡·á¸ñÀûÀ¸·Î ÁÖ·Î ÇǺÎÀÇ ¾Ç¼ºÁ¾¾ç(¾Ï)¿¡ »ç¿ëµÈ´Ù. |
||
| ¿µ¹® | adulthood | ÇÑ±Û | ¼ºÀαâ |
|---|---|---|---|
| ¼³¸í | žƿ¡¼ ¼Ò¾Æ±â¿Í û³â±â¸¦ °ÅÃÄ ¼ºÀåÀÌ ¿Ï·áµÈ ½ÃÁ¡¿¡¼ ³ë³â±â±îÁöÀÇ ±â°£ º¸Åë 20~60¼¼±îÁö¸¦ ¸»ÇÑ´Ù. ÇÑâ ÀÏÇÒ ½Ã±â·Î¼ »çȸ»ýȰ°ú °¡Á¤»ýȰ¿¡ ÀÖ¾î¼ Ãæ½ÇÇÏ°Ô ³ë·ÂÇÏ´Â ½Ã±âÀ̱⵵ ÇÏ´Ù. ±×·¯³ª ü·ÂÀº 25¼¼¸¦ Á¤Á¡À¸·Î ¿¬·É°ú ÇÔ²² Çϰ¼±À» °È´Â ½Ã±â¿¡ ÇØ´çÇϸç, ƯÈ÷ 40¼¼ Áß¹ÝÀ» °íºñ·Î ü·Â°ú ¿îµ¿´É·ÂÀÌ ¼è¾àÇØÁö±â ¶§¹®¿¡ Àû´çÇÑ ¿îµ¿ÀÌ ÇÊ¿äÇÏ°Ô µÇ´Â ½Ã±âÀ̱⵵ ÇÏ´Ù. ¶Ç ¾Ï, ´ç´¢º´, ½ÉÀ庴, °íÇ÷¾Ð, µ¿¸Æ°æÈÁõ µî ¼ÒÀ§ ¼ºÀκ´ÀÌ ³ªÅ¸³ª´Â ¶§À̸ç, ƯÈ÷ ½É±Ù°æ»ö, ³úÁßdz µî°ú °°Àº µ¿¸Æ°æÈ°¡ ¿øÀÎÀÌ µÇ´Â ÁúȯÀÌ 40´ë¿¡ Áõ°¡ÇÏ´Â °æÇâÀÌ Àֱ⠶§¹®¿¡ Á¤±âÀûÀ¸·Î °ËÁøÀ» ¹Þ¾Æ º´ÀÇ ¿¹¹æ°ú Á¶±â¹ß°ß¿¡ ½Å°æÀ» ½á¾ß ÇÏ´Â ½Ã±âÀÌ´Ù. |
||
| ¿µ¹® | dermatosis | ÇÑ±Û | ÇǺκ´ |
|---|---|---|---|
| ¼³¸í | ÇǺο¡ »ý±â´Â ¸ðµç º´ÀÇ ÃÑĪ. ÇǺδ ½ÅüÀÇ Ç¥¸éÀ» µ¤°í ÀÖÀ¸¹Ç·Î ¿Ü°è·ÎºÎÅÍ ÀÚ±ØÀ̳ª ¿©·¯ º´¿øÃ¼¿¡ Á÷Á¢ Á¢Ã赃 ±âȸ°¡ ¸¹°í, ü³»·ÎºÎÅÍ ¿µÇâÀ» °ÇÏ°Ô ¹Þ´Â´Ù. ´õ¿íÀÌ ÇǺÎÀÇ ±Ù¼ÒÇÑ º¯Èµµ ´«À¸·Î º¸°í ¼ÕÀ¸·Î ¸¸Áú ¼ö ÀÖÀ¸¸ç, º´º¯ºÎÀÇ ÀϺθ¦ äÃëÇÏ¿© º´¸®Á¶Á÷ÇÐÀûÀ¸·Î °Ë»çÇϰųª, ¹Ì»ý¹°ÀÇ °Ë»ö µîÀÇ °Ë»ç¸¦ Çϱ⠽±°í, °³°³ÀÇ Áúº´ÀÇ Áø´ÜÀ» ¸íÈ®ÇÏ°Ô ÇÏ´Â °ÍÀÌ ¿ëÀÌÇϹǷÎ, ±× Á¾·ù´Â ´Ù¸¥ Àå±âÀÇ ±×°Í¿¡ ºñÇÏ¿© »ó´çÇÑ ¼ö¿¡ À̸£¸ç, º´¸íµµ º¹Àâ ´Ù¾çÇÏ´Ù. Å©°Ô ³ª´©¸é ´ÙÀ½°ú °°´Ù. º¯È°¡ ÇǺο¡ ÇÑÁ¤µÈ °Í¿¡´Â ¹ÝÁ¡-Á¡ µîÀÌ ÀÖ°í, Àü½Å¿¡ ¹ÌÄ¡´Â °Í¿¡´Â ¾Æ±³Áúº´, ºñŸ¹Î°áÇ̼º ÇǺκ´, ³»ºÐºñÀå¾Ö¼º ÇǺκ´ µîÀÌ Æ÷ÇԵȴÙ. ´Ù¸¸ ÇǺθ¦ Á¦¿ÜÇÑ ºÎºÐÀ» ÇǺο¡ ´ëÇÏ¿© Àü½ÅÀ¸·Î °£ÁÖÇÏ´Â °æ¿ì, º¯È°¡ ÇǺο¡¸¸ ÇÑÁ¤µÇ´Â °ÍÀº Àû°í, ´ëºÎºÎºÐÀÇ ÇǺκ´Àº Ç÷¾×ÀÇ º¯È³ª °£±â´ÉÀå¾Ö µîÀÇ Àü½ÅÇö»óÀ» ¼ö¹ÝÇÑ´Ù. ¼¼±Õ-¹ÙÀÌ·¯½º µîÀÇ º´¿øÃ¼°¡ ¿øÀÎÀÎ Áúº´¿¡´Â ¼öµÎ-³ó°¡Áø-¸Åµ¶ µîÀÌ ÀÖ°í, °¢°¢ Àü¿°ÇÏÁö¸¸, ½ÀÁø-¹ÝÁ¡-Á¾¾ç ¶Ç´Â ¾Æ±³Áúº´ µîÀº Àü¿°ÇÏÁö ¾Ê´Â´Ù. ÇǺκ´ÀÇ ³»ÀÎÀ¸·Î´Â À§ÀåÀå¾Ö-°£º´-ÄáÆÏº´-¹°Áú´ë»çÀå¾Ö-Ç÷¾×Áúȯ-³»ÀåÁ¾¾ç-³»ºÐºñÀå¾Ö µîÀ» µé ¼ö ÀÖ´Ù. |
||
| GIDAANT | Gender Identity Disorder of Adolescence or Adulthood, Non-transsexual Type |
|---|---|
| Ig | Immuno-globulin IgA; Immuno-globulin A; (27)(30)60(100) - (170)(80)(250)380 mg/dL |
| IGA | infantile genetic agranulocytosis |
| IgA | immunoglobulin A |
| S-IgA | secretory immunoglobulin A |
| LABD | Linear IgA bullous dermatosis |
|---|---|
| IgA-D | IgA deficiency |
| IgA GN | IgA glomerulonephritis |
| IgA-IC | IgA immune complex |
| IgA NP | IgA nephropathy |
| linear IgA bullous disease in children | A rare self-limiting bullous disease, chiefly of the trunk, perioral, and pelvic areas, with onset in the first decade, successively less severe recurrences, and total remission at adolescence; linear epidermal basement membrane zone deposit of IgA is found in involved and in normal skin. Synonym: linear IgA bullous disease in children. (05 Mar 2000) |
|---|---|
| glomerulonephritis, IgA | Chronic form of glomerulonephritis characterised by recurring haematuria with only slight proteinuria and by deposits of IgA immunoglobulin in the mesangial areas of the renal glomeruli. It usually occurs in young males. (12 Dec 1998) |
| secretory component of IgA | <immunology, protein> A polypeptide chain of about 60 kD that aids secretion of the IgA, a portion of the IgA receptor on the plasmalemma of the inner side of the epithelial cells lining the gut, which is proteolysed when the IgA receptor complex has travelled through the cell after receptor mediated endocytosis at the inner face, to the outer (luminal) face. (18 Nov 1997) |
| IgA | <immunology> Major class of immunoglobulin of external secretions in mammals, also found in serum and body fluids such as tears and saliva and in the respiratory, reproductive, urinary and gastrointestinal tracts. Immunoglobulin A protects the bodys mucosal surfaces from infection and in secretions, it is found as a dimer (400 kD) joined by a short J chain and linked to a secretory portion or transport piece. In serum found as a monomer (170 kD). Immunoglobulin A is the main mechanism for providing local immunity against infections in the gut or respiratory tract and may act by reducing the binding between an immunoglobulin A coated micro organism and a host epithelial cell. Present in human colostrum but not transferred across the placenta. Have heavy chains. (30 Mar 1998) |
| IgA deficiency | A dysgammaglobulinaemia characterised by a deficiency of IgA. (12 Dec 1998) |
| IgA nephropathy | <nephrology, pathology> This is a form of glomerulonephritis that results from the deposition of circulating IgA antibody in the kidney tissues. Inflammation of the glomerulus (glomerulonephritis) is the result. This condition may present as acute glomerulonephritis, chronic glomerulonephritis or rapidly progressive glomerulonephritis. Berger's is usually detected in an individual with one or two bouts of bloody urine (usually begins during or soon after a respiratory infection) and no other symptoms of renal disease. Only rarely, will Berger's disease permanently affect kidney function and progress to chronic renal failure. This renal disorder more commonly affects males in the 16-40 age group. Origin: Gr. Pathos = disease (27 Sep 1997) |
| IgA, secretory | The principle ig found in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. It is composed of two to four molecules of 7s IgA and one molecule each of j chain and secretory component (sc), also called secretory piece. Molecular weight appr. 400,000. (12 Dec 1998) |
| IgA-specific serine endopeptidase | <enzyme> Extracellular microbial enzymes whose only substrate is human IgA of the iga1 subclass; cleave the immunoglobulin at a specific internal prolyl-threonyl peptide bond in the heavy chain to yield intact faba and fca fragments; consider also EC 3.4.24.13 Registry number: EC 3.4.21.72 Synonym: immunoglobulin a(1) protease, iga1 protease, immunoglobulin a1 protease, IgA protease (26 Jun 1999) |
| programming, linear | A technique of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimised, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. It is different from computer programming, although problems using linear programming techniques may be programmed on a computer. (12 Dec 1998) |
| non-linear | Not linear. (05 Dec 1998) |
| superficial linear keratitis | Spontaneous, painful keratitis with epithelial erosion and folds in Bowman's membrane. (05 Mar 2000) |
| linear | Pertaining to or resembling a line. Origin: L. Linearis (18 Nov 1997) |
| linear absorption coefficient | That fraction of ionizing radiation absorbed in a unit thickness of a substance or tissue. See: absorption coefficient. (05 Mar 2000) |
| linear acceleration | The rate of change of velocity without a change in direction; e.g., when the speed of an aircraft increases while flying a straight pathway. (05 Mar 2000) |
| linear accelerator | <apparatus> A sophisticated external beam radiotherapy machine which has the capabilities of focussing irradiation (although not very finely). Acronym: LinAC (16 Dec 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|